Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0EB9M
|
|||
Drug Name |
PMID28627961-Compound-22
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Glenmark Pharmaceuticals S.A
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H24ClF4N5O2
|
|||
Canonical SMILES |
CC(C)(C)C(=O)NCC1=C(C(=C(C=C1)Cl)C(=O)NC2=CC=CC3=C2N=CN=C3NC4=CC=CC(=C4)C(F)(F)F)F
|
|||
InChI |
1S/C28H24ClF4N5O2/c1-27(2,3)26(40)34-13-15-10-11-19(29)21(22(15)30)25(39)38-20-9-5-8-18-23(20)35-14-36-24(18)37-17-7-4-6-16(12-17)28(31,32)33/h4-12,14H,13H2,1-3H3,(H,34,40)(H,38,39)(H,35,36,37)
|
|||
InChIKey |
NPMRJEGXUPKUTE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin E synthase (PTGES) | Target Info | Inhibitor | [1] |
Target's Patent Info | Prostaglandin E synthase (PTGES) | Target's Patent Info | [1] | |
BioCyc | C20 prostanoid biosynthesis | |||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Arachidonic acid metabolism | |||
Eicosanoid Synthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Sep;27(9):1047-1059. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.